Biomea Fusion, Inc. (BMEA)
1.735
+0.04
(+2.06%)
USD |
NASDAQ |
Sep 11, 16:00
1.735
0.00 (0.00%)
After-Hours: 16:28
Biomea Fusion Gross Profit (TTM) : -0.513M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.513M |
| March 31, 2026 | -0.993M |
| December 31, 2025 | -1.415M |
| September 30, 2025 | -1.837M |
| June 30, 2025 | -1.837M |
| March 31, 2025 | -1.737M |
| December 31, 2024 | -1.689M |
| September 30, 2024 | -2.35M |
| June 30, 2024 | -3.06M |
| March 31, 2024 | -3.716M |
| December 31, 2023 | -4.201M |
| September 30, 2023 | -3.397M |
| June 30, 2023 | -2.631M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.887M |
| December 31, 2022 | -1.148M |
| September 30, 2022 | -1.11M |
| June 30, 2022 | -1.016M |
| March 31, 2022 | -1.026M |
| December 31, 2021 | -0.9523M |
| September 30, 2021 | -0.67M |
| June 30, 2021 | -0.4643M |
| March 31, 2021 | -0.1423M |
| December 31, 2020 | -0.05M |
| September 30, 2020 | -0.0443M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| REGENXBIO, Inc. | 135.34M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |